The Cancer Tissue Diagnostic Market has exhibited an ascending trend, where its value is estimated to go from USD 15,302.2 million in 2024 to USD 23,516.2 million in 2034. Adoption of cancer tissue diagnostics is exhibiting a CAGR of 4.5% from 2024 to 2034. The market was valued at USD 14,651.0 million in 2023 and is anticipated to exhibit a y-o-y growth of 4.4% in 2024.
| Attributes | Key Insights |
|---|---|
| Base Value (2023) | USD 14,651.0 million |
| Global Cancer Tissue Diagnostic Market Size (2024E) | USD 15,302.2 million |
| Cancer Tissue Diagnostic Market Value (2034F) | USD 23,516.2 million |
| Value-based CAGR (2024 to 2034) | 4.5% |
The market witnessed remarkable expansion in recent years due to the growing demand for high-throughput cancer tissue diagnostic kits. This increase in demand for cancer tissue diagnostics is due to its ability to quickly process a large volume of samples and provide effective diagnostic solutions.
Growing demand for genetic testing and analysis of personalized medicine and genomic research & developments is further anticipating market growth. The market is set to surge as several pharmaceutical companies invest in developing and manufacturing sophisticated cancer tissue diagnostics.
The global cancer tissue diagnostic market recorded a historical CAGR of 3.4% from 2019 to 2023. Historical factors such as the dependency on hospitals, specialty centers, and diagnostics centers have contributed to the development of innovative technologies in cancer tissue diagnostics. Innovative technologies have significantly enhanced the efficiency of diagnostics processes in pharmacogenomics, genetic disorders, and oncology disease diagnosis, leading to increased applications.
Looking forward to the future, the market is projected to grow significantly. The shift is majorly attributed to the rising preference of healthcare professionals for early diagnosis and prognosis of cancer. Growing emphasis on personalized cancer treatments and the development of targeted therapies is fueling growth of cancer tissue diagnostics kits.
Strategic initiatives such as mergers and acquisitions taken by manufacturing companies to develop new products are projected to further propel market growth. The rapid development of technology and innovative diagnostic methodologies have prompted market players to boost their product offerings and enhance their market presence.
For instance, in March 2021, United States-based Agilent Technologies Inc. acquired Resolution Bioscience to strengthen its leadership position in cancer diagnostics. Hence, these strategic collaborations and acquisitions aim to develop innovative solutions to address emerging market needs and stay at the forefront of innovations in cancer diagnostics.
The rising prevalence of different types of cancers among the general population has majorly contributed to the growing adoption of cancer tissue diagnosis in the healthcare fraternity.
Rising demand for technologically progressed diagnostics for effective diagnosis has encouraged manufacturers to develop diagnostic kits that are efficient and affordable. This thriving landscape of clinical trials in research & development of novel cancer diagnostics is set to contribute to the growth of the market by 2034.
Growing application of cutting-edge molecular diagnostics technologies, such as next-generation sequencing and liquid biopsy techniques for accurate, personalized, and effective diagnosis, further augment the market.
The rapid and comprehensive analysis of patient genetic material with unprecedented accuracy and depth contributes to its surging adoption. Other advantages, such as the ability of liquid biopsies to monitor disease progression over time and the potential for early detection & treatment adjustment, propel market growth.
Favorable initiatives taken by the government for the manufacturing and exporting of diagnostic kits & reagents have also played a pivotal role in the growth of the market. For instance, India has lifted export restrictions on diagnostic kits and reagents, including equipment such as cancer tissue diagnostics kits.
Several cancer diagnostics manufacturing companies and healthcare facilities have seen a sizeable gap between the availability of skilled professionals and their needs. This shortage of experienced and skilled individuals, along with limited awareness, is hampering the market. Inadequate healthcare infrastructure and primary healthcare facilities, particularly in rural areas, are further limiting the accessibility of cancer tissue diagnostics.
The research study indicates that there are some underexplored fields of diagnostic product manufacturers in key countries. In accordance with the forecast, China and India are going to be a sizable area for cancer tissue diagnostic manufacturers to grow. But, the United States, United Kingdom, and Germany are taking advantage of their established markets, which means their growth rates are stable.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| United States | 3.1% |
| China | 6.8% |
| Germany | 2.5% |
| United Kingdom | 2.1% |
| India | 5.8% |
The United States dominates the global market with a 91.7% share in 2023 and is projected to continue experiencing stable growth throughout the forecast period. Increasing prevalence of cancer among the general population is fueling the adoption of cancer tissue diagnostics in the country, pushing market growth.
For instance, according to the statistics published by the Centers for Disease Control and Prevention in April 2023, in 2019, around 224,733 new cases of prostate cancer were reported in the United States. Increasing prevalence of cancer in the country is largely due to genetic complexity, rising drug use among the millennial population, and sedentary lifestyle of the general population.
China is set to lead the market at a CAGR of 6.8% through 2034. Research universities' increasing investment in cancer diagnosis programs and precision medicine research is propelling market growth in China.
The growing focus of regulatory bodies on initiating new programs for screening genetic mutations among individuals in China is contributing to the market's growth. For instance, according to a journal published by Precision Cancer Medicine in 2021, Fudan University Shanghai Cancer Center (FUSCC) in China launched a new program for screening BRCA mutations using next-generation sequencing (NGS).
In 2023, Germany held a significant global market share of 25% and is anticipated to maintain considerable growth over the forecast period. Increasing awareness of the surging prevalence of breast cancer among women in Germany is propelling growth of the tissue diagnostics product market.
Increasing prevalence of breast cancer has led to a surging adoption of cancer tissue diagnostics products, prompting manufacturers to broaden their distribution channels. For instance, in April 2023, Cerca Biotech collaborated with Sysmex Europe, a laboratory equipment supplier in Germany, to distribute their RT-qPCR molecular breast cancer assay in 13 European markets.
The segmented cancer tissue diagnostic analysis is mentioned in the following subsection. Based on comprehensive studies, the molecular diagnostics test kits segment is leading the product type category. Similarly, the breast cancer segment is commanding the cancer type category.
| Product Type | Molecular Diagnostics Test Kits |
|---|---|
| Value CAGR (2024 to 2034) | 3.7% |
The molecular diagnostics test kit segment is set to lead the market, accounting for 42.7% market share in 2023, and is projected to grow at a substantial rate by 2034. Growth of molecular diagnostic test kits is propelled by increasing demand for personalized medicine, genomic research developments, and rapid diagnostic solutions. Moreover, their ability to conduct essential testing of infectious diseases with rapid and accurate results anticipates its growth.
| Cancer Type | Value CAGR (2024 to 2034) |
|---|---|
| Breast Cancer | 5.1% |
| Lung Cancer | 4.5% |
The breast cancer segment held a market share of 22.7% in 2023 and is projected to continue experiencing high growth throughout the forecast period. The rising prevalence of breast cancer among women due to aging, genetic mutations, and changing lifestyles has become a notable concern in recent years. Increasing prevalence of breast cancer is surging growth of the breast cancer segment through the increased use of cancer tissue diagnostics.
| End-user | Value CAGR (2024 to 2034) |
|---|---|
| Hospitals | 5.4% |
| Specialty Centers | 4.1% |
The hospital segment dominated the market and held a market share of 34.4% in 2023. Increasing awareness of different types of cancers has contributed to rising patient footfall in hospital facilities for routine check-ups. In addition, continuously improving healthcare infrastructure in developed and developing countries propels its expansion.
In the dynamic market landscape, companies emphasize launching new products to broaden their portfolio. Moreover, they are focusing on strategic collaborations and partnerships to address evolving market demands and extend their geographic footprint. Leading companies are directed toward product launches and developments to strengthen their market hold.
For instance
Table 1: Global Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Product
Table 2: Global Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product
Table 3: Global Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Cancer
Table 4: Global Market Value (US$ million) Analysis and Forecast 2019 to 2034, by End User
Table 5: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country
Table 6: North America Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Product
Table 7: North America Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product
Table 8: North America Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Cancer
Table 9: North America Market Value (US$ million) Analysis and Forecast 2019 to 2034, by End User
Table 10: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country
Table 11: Latin America Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Product
Table 12: Latin America Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product
Table 13: Latin America Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Cancer
Table 14: Latin America Market Value (US$ million) Analysis and Forecast 2019 to 2034, by End User
Table 15: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country
Table 16: East Asia Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Product
Table 17: East Asia Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product
Table 18: East Asia Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Cancer
Table 19: East Asia Market Value (US$ million) Analysis and Forecast 2019 to 2034, by End User
Table 20: South Asia and Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country
Table 21: South Asia and Pacific Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Product
Table 22: South Asia and Pacific Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product
Table 23: South Asia and Pacific Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Cancer
Table 24: South Asia and Pacific Market Value (US$ million) Analysis and Forecast 2019 to 2034, by End User
Table 25: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country
Table 26: Western Europe Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Product
Table 27: Western Europe Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product
Table 28: Western Europe Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Cancer
Table 29: Western Europe Market Value (US$ million) Analysis and Forecast 2019 to 2034, by End User
Table 30: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country
Table 31: Eastern Europe Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Product
Table 32: Eastern Europe Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product
Table 33: Eastern Europe Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Cancer
Table 34: Eastern Europe Market Value (US$ million) Analysis and Forecast 2019 to 2034, by End User
Table 35: Middle East and Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country
Table 36: Middle East and Africa Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Product
Table 37: Middle East and Africa Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product
Table 38: Middle East and Africa Market Value (US$ million) Analysis and Forecast 2019 to 2034, by Cancer
Table 39: Middle East and Africa Market Value (US$ million) Analysis and Forecast 2019 to 2034, by End User
Figure 1: Global Market Value (US$ million) Analysis, 2019 to 2023
Figure 2: Global Market Forecast and Y-o-Y Growth, 2024 to 2034
Figure 3: Global Market Absolute $ Opportunity (US$ million) Analysis, 2024 to 2034
Figure 4: Global Market Value Share (%) Analysis 2024 to 2034, by Product
Figure 5: Global Market Y-o-Y Growth (%) Analysis 2024 to 2034, by Product
Figure 6: Global Market Attractiveness Analysis 2024 to 2034, by Product
Figure 7: Global Market Value Share (%) Analysis 2024 to 2034, by Cancer
Figure 8: Global Market Y-o-Y Growth (%) Analysis 2024 to 2034, by Cancer
Figure 9: Global Market Attractiveness Analysis 2024 to 2034, by Cancer
Figure 10: Global Market Value Share (%) Analysis 2024 to 2034, by End User
Figure 11: Global Market Y-o-Y Growth (%) Analysis 2024 to 2034, by End User
Figure 12: Global Market Attractiveness Analysis 2024 to 2034, by End User
Figure 13: Global Market Value Share (%) Analysis 2024 to 2034, by Region
Figure 14: Global Market Y-o-Y Growth (%) Analysis 2024 to 2034, by Region
Figure 15: Global Market Attractiveness Analysis 2024 to 2034, by Region
Figure 16: North America Market Value (US$ million) Analysis, 2019 to 2023
Figure 17: North America Market Value (US$ million) Forecast, 2024 to 2034
Figure 18: North America Market Value Share, by Product (2024E)
Figure 19: North America Market Value Share, by Cancer (2024E)
Figure 20: North America Market Value Share, by End User (2024E)
Figure 21: North America Market Value Share, by Country (2024E)
Figure 22: North America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Cancer, 2024 to 2034
Figure 24: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 25: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 26: United States Market Value Proportion Analysis, 2024
Figure 27: Global Vs. United States Growth Comparison, 2024 to 2034
Figure 28: United States Market Share Analysis (%) by Product, 2024 to 2034
Figure 29: United States Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 30: United States Market Share Analysis (%) by End User, 2024 to 2034
Figure 31: Canada Market Value Proportion Analysis, 2024
Figure 32: Global Vs. Canada. Growth Comparison, 2024 to 2034
Figure 33: Canada Market Share Analysis (%) by Product, 2024 to 2034
Figure 34: Canada Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 35: Canada Market Share Analysis (%) by End User, 2024 to 2034
Figure 36: Mexico Market Value Proportion Analysis, 2024
Figure 37: Global Vs. Mexico Growth Comparison, 2024 to 2034
Figure 38: Mexico Market Share Analysis (%) by Product, 2024 to 2034
Figure 39: Mexico Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 40: Mexico Market Share Analysis (%) by End User, 2024 to 2034
Figure 41: Latin America Market Value (US$ million) Analysis, 2019 to 2023
Figure 42: Latin America Market Value (US$ million) Forecast, 2024 to 2034
Figure 43: Latin America Market Value Share, by Product (2024E)
Figure 44: Latin America Market Value Share, by Cancer (2024E)
Figure 45: Latin America Market Value Share, by End User (2024E)
Figure 46: Latin America Market Value Share, by Country (2024E)
Figure 47: Latin America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by Cancer, 2024 to 2034
Figure 49: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 50: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 51: Brazil Market Value Proportion Analysis, 2024
Figure 52: Global Vs. Brazil. Growth Comparison, 2024 to 2034
Figure 53: Brazil Market Share Analysis (%) by Product, 2024 to 2034
Figure 54: Brazil Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 55: Brazil Market Share Analysis (%) by End User, 2024 to 2034
Figure 56: Chile Market Value Proportion Analysis, 2024
Figure 57: Global Vs. Chile Growth Comparison, 2024 to 2034
Figure 58: Chile Market Share Analysis (%) by Product, 2024 to 2034
Figure 59: Chile Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 60: Chile Market Share Analysis (%) by End User, 2024 to 2034
Figure 61: East Asia Market Value (US$ million) Analysis, 2019 to 2023
Figure 62: East Asia Market Value (US$ million) Forecast, 2024 to 2034
Figure 63: East Asia Market Value Share, by Product (2024E)
Figure 64: East Asia Market Value Share, by Cancer (2024E)
Figure 65: East Asia Market Value Share, by End User (2024E)
Figure 66: East Asia Market Value Share, by Country (2024E)
Figure 67: East Asia Market Attractiveness Analysis by Product, 2024 to 2034
Figure 68: East Asia Market Attractiveness Analysis by Cancer, 2024 to 2034
Figure 69: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 70: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 71: China Market Value Proportion Analysis, 2024
Figure 72: Global Vs. China Growth Comparison, 2024 to 2034
Figure 73: China Market Share Analysis (%) by Product, 2024 to 2034
Figure 74: China Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 75: China Market Share Analysis (%) by End User, 2024 to 2034
Figure 76: Japan Market Value Proportion Analysis, 2024
Figure 77: Global Vs. Japan Growth Comparison, 2024 to 2034
Figure 78: Japan Market Share Analysis (%) by Product, 2024 to 2034
Figure 79: Japan Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 80: Japan Market Share Analysis (%) by End User, 2024 to 2034
Figure 81: South Korea Market Value Proportion Analysis, 2024
Figure 82: Global Vs. South Korea Growth Comparison, 2024 to 2034
Figure 83: South Korea Market Share Analysis (%) by Product, 2024 to 2034
Figure 84: South Korea Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 85: South Korea Market Share Analysis (%) by End User, 2024 to 2034
Figure 86: South Asia and Pacific Market Value (US$ million) Analysis, 2019 to 2023
Figure 87: South Asia and Pacific Market Value (US$ million) Forecast, 2024 to 2034
Figure 88: South Asia and Pacific Market Value Share, by Product (2024E)
Figure 89: South Asia and Pacific Market Value Share, by Cancer (2024E)
Figure 90: South Asia and Pacific Market Value Share, by End User (2024E)
Figure 91: South Asia and Pacific Market Value Share, by Country (2024E)
Figure 92: South Asia and Pacific Market Attractiveness Analysis by Product, 2024 to 2034
Figure 93: South Asia and Pacific Market Attractiveness Analysis by Cancer, 2024 to 2034
Figure 94: South Asia and Pacific Market Attractiveness Analysis by End User, 2024 to 2034
Figure 95: South Asia and Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 96: India Market Value Proportion Analysis, 2024
Figure 97: Global Vs. India Growth Comparison, 2024 to 2034
Figure 98: India Market Share Analysis (%) by Product, 2024 to 2034
Figure 99: India Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 100: India Market Share Analysis (%) by End User, 2024 to 2034
Figure 101: ASEAN Countries Market Value Proportion Analysis, 2024
Figure 102: Global Vs. ASEAN Countries Growth Comparison, 2024 to 2034
Figure 103: ASEAN Countries Market Share Analysis (%) by Product, 2024 to 2034
Figure 104: ASEAN Countries Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 105: ASEAN Countries Market Share Analysis (%) by End User, 2024 to 2034
Figure 106: Australia and New Zealand Market Value Proportion Analysis, 2024
Figure 107: Global Vs. Australia and New Zealand Growth Comparison, 2024 to 2034
Figure 108: Australia and New Zealand Market Share Analysis (%) by Product, 2024 to 2034
Figure 109: Australia and New Zealand Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 110: Australia and New Zealand Market Share Analysis (%) by End User, 2024 to 2034
Figure 111: Western Europe Market Value (US$ million) Analysis, 2019 to 2023
Figure 112: Western Europe Market Value (US$ million) Forecast, 2024 to 2034
Figure 113: Western Europe Market Value Share, by Product (2024E)
Figure 114: Western Europe Market Value Share, by Cancer (2024E)
Figure 115: Western Europe Market Value Share, by End User (2024E)
Figure 116: Western Europe Market Value Share, by Country (2024E)
Figure 117: Western Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 118: Western Europe Market Attractiveness Analysis by Cancer, 2024 to 2034
Figure 119: Western Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 120: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 121: United Kingdom Market Value Proportion Analysis, 2024
Figure 122: Global Vs. United Kingdom Growth Comparison, 2024 to 2034
Figure 123: United Kingdom Market Share Analysis (%) by Product, 2024 to 2034
Figure 124: United Kingdom Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 125: United Kingdom Market Share Analysis (%) by End User, 2024 to 2034
Figure 126: Germany Market Value Proportion Analysis, 2024
Figure 127: Global Vs. Germany Growth Comparison, 2024 to 2034
Figure 128: Germany Market Share Analysis (%) by Product, 2024 to 2034
Figure 129: Germany Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 130: Germany Market Share Analysis (%) by End User, 2024 to 2034
Figure 131: Italy Market Value Proportion Analysis, 2024
Figure 132: Global Vs. Italy Growth Comparison, 2024 to 2034
Figure 133: Italy Market Share Analysis (%) by Product, 2024 to 2034
Figure 134: Italy Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 135: Italy Market Share Analysis (%) by End User, 2024 to 2034
Figure 136: France Market Value Proportion Analysis, 2024
Figure 137: Global Vs. France Growth Comparison, 2024 to 2034
Figure 138: France Market Share Analysis (%) by Product, 2024 to 2034
Figure 139: France Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 140: France Market Share Analysis (%) by End User, 2024 to 2034
Figure 141: Spain Market Value Proportion Analysis, 2024
Figure 142: Global Vs. Spain Growth Comparison, 2024 to 2034
Figure 143: Spain Market Share Analysis (%) by Product, 2024 to 2034
Figure 144: Spain Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 145: Spain Market Share Analysis (%) by End User, 2024 to 2034
Figure 146: Nordic Countries Market Value Proportion Analysis, 2024
Figure 147: Global Vs. Nordic Countries Growth Comparison, 2024 to 2034
Figure 148: Nordic Countries Market Share Analysis (%) by Product, 2024 to 2034
Figure 149: Nordic Countries Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 150: Nordic Countries Market Share Analysis (%) by End User, 2024 to 2034
Figure 151: BENELUX Market Value Proportion Analysis, 2024
Figure 152: Global Vs. BENELUX Growth Comparison, 2024 to 2034
Figure 153: BENELUX Market Share Analysis (%) by Product, 2024 to 2034
Figure 154: BENELUX Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 155: BENELUX Market Share Analysis (%) by End User, 2024 to 2034
Figure 156: Eastern Europe Market Value (US$ million) Analysis, 2019 to 2023
Figure 157: Eastern Europe Market Value (US$ million) Forecast, 2024 to 2034
Figure 158: Eastern Europe Market Value Share, by Product (2024E)
Figure 159: Eastern Europe Market Value Share, by Cancer (2024E)
Figure 160: Eastern Europe Market Value Share, by End User (2024E)
Figure 161: Eastern Europe Market Value Share, by Country (2024E)
Figure 162: Eastern Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 163: Eastern Europe Market Attractiveness Analysis by Cancer, 2024 to 2034
Figure 164: Eastern Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 165: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 166: Russia Market Value Proportion Analysis, 2024
Figure 167: Global Vs. Russia Growth Comparison, 2024 to 2034
Figure 168: Russia Market Share Analysis (%) by Product, 2024 to 2034
Figure 169: Russia Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 170: Russia Market Share Analysis (%) by End User, 2024 to 2034
Figure 171: Hungary Market Value Proportion Analysis, 2024
Figure 172: Global Vs. Hungary Growth Comparison, 2024 to 2034
Figure 173: Hungary Market Share Analysis (%) by Product, 2024 to 2034
Figure 174: Hungary Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 175: Hungary Market Share Analysis (%) by End User, 2024 to 2034
Figure 176: Poland Market Value Proportion Analysis, 2024
Figure 177: Global Vs. Poland Growth Comparison, 2024 to 2034
Figure 178: Poland Market Share Analysis (%) by Product, 2024 to 2034
Figure 179: Poland Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 180: Poland Market Share Analysis (%) by End User, 2024 to 2034
Figure 181: Middle East and Africa Market Value (US$ million) Analysis, 2019 to 2023
Figure 182: Middle East and Africa Market Value (US$ million) Forecast, 2024 to 2034
Figure 183: Middle East and Africa Market Value Share, by Product (2024E)
Figure 184: Middle East and Africa Market Value Share, by Cancer (2024E)
Figure 185: Middle East and Africa Market Value Share, by End User (2024E)
Figure 186: Middle East and Africa Market Value Share, by Country (2024E)
Figure 187: Middle East and Africa Market Attractiveness Analysis by Product, 2024 to 2034
Figure 188: Middle East and Africa Market Attractiveness Analysis by Cancer, 2024 to 2034
Figure 189: Middle East and Africa Market Attractiveness Analysis by End User, 2024 to 2034
Figure 190: Middle East and Africa Market Attractiveness Analysis by Country, 2024 to 2034
Figure 191: Saudi Arabia Market Value Proportion Analysis, 2024
Figure 192: Global Vs. Saudi Arabia Growth Comparison, 2024 to 2034
Figure 193: Saudi Arabia Market Share Analysis (%) by Product, 2024 to 2034
Figure 194: Saudi Arabia Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 195: Saudi Arabia Market Share Analysis (%) by End User, 2024 to 2034
Figure 196: Türkiye Market Value Proportion Analysis, 2024
Figure 197: Global Vs. Türkiye Growth Comparison, 2024 to 2034
Figure 198: Türkiye Market Share Analysis (%) by Product, 2024 to 2034
Figure 199: Türkiye Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 200: Türkiye Market Share Analysis (%) by End User, 2024 to 2034
Figure 201: South Africa Market Value Proportion Analysis, 2024
Figure 202: Global Vs. South Africa Growth Comparison, 2024 to 2034
Figure 203: South Africa Market Share Analysis (%) by Product, 2024 to 2034
Figure 204: South Africa Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 205: South Africa Market Share Analysis (%) by End User, 2024 to 2034
Figure 206: Other African Union Market Value Proportion Analysis, 2024
Figure 207: Global Vs. Other African Union Growth Comparison, 2024 to 2034
Figure 208: Other African Union Market Share Analysis (%) by Product, 2024 to 2034
Figure 209: Other African Union Market Share Analysis (%) by Cancer, 2024 to 2034
Figure 210: Other African Union Market Share Analysis (%) by End User, 2024 to 2034
The market is set to reach USD 15,302.2 million in 2024.
Demand for cancer tissue diagnostics is slated to rise at a 4.5% CAGR by 2034.
The market is set to reach USD 23,516.2 million in 2034.
Abbott Laboratories, F. Hoffman-La Roche Ltd., and Thermo Fisher Scientific Inc. are the key players.
Breast cancer segment is estimated to hold a significant market share in 2024.
Explore Life Science & Biotechnology Insights
Cancer Tissue Diagnostic Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
